Environmental and genetic factors that influence the development of congenital heart malformations
Abstract
Congenital heart diseases are a group of disorders of the heart and blood vessels, currently the causes aren’t known, however we can deduce that they occur in the period of the 3rd to 10th week of pregnancy. The objective of this article is to know the factors that occur (environmental and genetic) during gestational age and may predispose to the development of congenital heart malformations.
At present we know that several environmental factors (that surround the mother during gestational age) can influence the correct development of the product, such as the use of drugs, falls, the lack of nutrients in the diet, the lack of control in pregnancy, etc. All this added to a large number of genetic factors.
That’s why it’s complicated to fix only one cause, and we can suspect that there are several factors that predispose these conditions.
Downloads
References
Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, W.B. Borden, et al.Heart disease and stroke statistics-2013 update: a report from de American Heart Association Circulation, 127 (2013), pp. 6-245
(NHGRI), N. H. (2017). National Human Genome Research Institute. Retrieved from National Human Genome Research Institute: https://www.genome.gov/glossarys/index.cfm?id=70
Bermejo E, C. L.–F. (2004). Vigilancia epidemiológica de anomalías congénitas en España, en los últimos 24 años. Revista de Dismorfología y Epidemiología, 57-82.
Caiju D, D. L. (2017). A meta- analysis about the screening role of pulse oximetry for congenital heart disease. Hindawi, 40-46.
Cardiopatía congénita. (2008). Retrieved from https://www.medicina.com/enfermedades/cardiopatia-congenita-enfermedad/tratamiento
Daniel L Varela, M. T.-A. (2018). Advanced Therapies for the management of adults with pulmonary arterial hypertension due to congenintal heart diseases. Openheart, 546 - 550.
Dolk H, Loane M. (2011). Defectos congénitos del corazón en Europa: prevalencia y mortalidad perinatal. EUROCAT, 841 - 845.
Gustavo Gabriel Mendieta-Alcántara, E. S.-A.-Z.-P.-A.-O. (2013). Incidencia de las cardiopatías congénitas y los factores asociados a la letalidad en niños nacidos en hospitales del Estado de México. Gaceta Médica de México, 617 - 634.
H.Sierra, E. C. (Volume 21, Issue 5, September–October 2014). Genes y variantes polimórficas asociadas a la enfermedad cardiovascular. Revista Colombiana de Cardiología, Pages 318-326.
Díez J. (2016). Apoptosis en enfermedades cardiovasculares . Cardiología y cirugía vascular , 15-20.
Nazer J. (2010). Prevención primaria de los defectos congénitos. Revista médica de Chile, 132-140.
J., B. H. (2010). Aspectos de interés en las cardiopatías congénitas. Optimización de recursos, estudio y manejo. Archivo de cardiología México, 65 - 68.
Juan Calderón-Colmenero, J. L.-S.-C.-M. (2010). Problemática de las cardiopatías congénitas en México. Propuesta de regionalización. Archivos de cardiología México.
Keith L. Moore, M. G. (2008). Embriología clínica. Elsevier Saunders.
OMS. ( 2015). Enfermedades cardiovasculares.
Khari P, et al (2010). Changing Mortaliti in Congenital Heart Disease. Journal of the American College of Cardiology, 85 - 90.
Salud, O. M. (13 de enero de 2015). Enfermedades cardiovasculares.
Salud, O. M. (13 de enero de 2015). Enfermedades cardiovasculares.
Siyeon, R. e. (2018). Endothelial deletion of Ino80 disrupts coronari angiogenesis and causes congenital heart diseases. Nature comunications, 69-75.
Than T. Haong, A. E. (2018). The congenital Heart disease genetic network study: Cohort description. Plos one, 55-63.
Van Der Linde D. (2011). Birth prevalence of congenital heart disease worldwide. Journal of the american College of Cardiology, 23-30.
Zhe, Y. P. (2018). Mutations in Hnrnpa1 cause congenital heart defects. JCI insight, 98-105.
Tuomisto, B.R. Binder, S. Ylä-Herttuala Genetics, genomics and proteomics in atherosclerosis research Ann Med, 37 (2005), pp. 323-332
